US-listed companies under D&O scrutiny
March 4 2016 by Nick Ferguson
-
Opinion: Risks from rising ESG regulations looming threat for businesses
- November 1
The D&O market is playing a watching brief as sanctions and litigation around ESG breaches and non-compliance play out.
-
Hong Kong’s Asia Insurance buoyant on D&O as reforms unleash demand
- September 17
The city's proposed corporate governance revamp and the newly launched RBC regime will open up opportunities for professional lines, and trigger industry consolidation as compliance costs mount, according to CEO Winnie Wong.
-
Conduct exclusion wordings get scrutinised as Segantii’s insider dealing case unfolds
- August 28
Ongoing criminal proceedings against one of Asia’s oldest hedge funds have highlighted the need for managers to constantly review policy coverage, limits and carriers' claims handling capability, according to financial lines underwriters.
-
Newline continues Sydney expansion with Andrew Yeung hire
- August 13
Yeung, who has been promoted to Australia head of D&O, will relocate to Sydney from Melbourne and work closely with Nick Beswick, head of professional indemnity.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
